At Boots HK Limited, we believe that research and innovation drive access to better healthcare solutions. While we do not manufacture directly, we collaborate with leading WHO-GMP, USFDA, and EU-approved manufacturers who continuously invest in R&D across peptides, oncology, hormones, injectables, and other niche therapeutic areas.
This collaboration enables us to source and supply cutting-edge APIs and intermediates to our clients globally, ensuring availability of the latest innovations in a compliant and timely manner.
Our strength lies in our global partnerships and a robust pharmaceutical supply chain. Boots HK complements its sourcing expertise with efficient logistics and GDP practices, ensuring seamless delivery across Asia Pacific, MENA, EU, Africa, and Latin America.
With access to diverse product portfolios from multiple trusted manufacturers, we ensure our clients benefit from flexibility, competitive pricing, and uninterrupted supply of high-quality APIs and intermediates.
Quality and compliance are non-negotiable at Boots HK. Every product we supply is backed by DMF, CEP, CTD, CoA, CoPP, and GMP certificates, ensuring adherence to the highest international standards.
Our operations are guided by a strict quality framework, ensuring transparency and trust. We partner exclusively with manufacturers who have proven track records of successful inspections by leading authorities such as US FDA, EMA, WHO GMP, ANVISA, COFEPRIS and others.
